Highest development stage: Preclinical

Development status: Inactive

Gram-positive activity

Additional information: Cullen, W. P., et al. "CP-38,295, a new polycyclic ether antibiotic. 16th Intersci." Conf. Antimicr. Agents & Chemoth. Paper. Vol. 234.